Logo

Nancy White

May 10, 2019

Inagene Diagnostics has appointed Nancy White as its CEO. White joined the firm in January as VP of sales and marketing. Prior to Inagene, White held several management roles at Novartis and Novartis Oncology from 2008 to 2018, including VP and franchise head, retina, region LACan; as well as global team lead, advancing commercial excellence, innovative customer models. Before Novartis, White served in multiple roles at Allergan from 2003 to 2008. Prior to Allergan, she held roles at Eli Lilly from 1999 to 2003. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.